Skip to main content
. 2020 Nov 30;21(23):9139. doi: 10.3390/ijms21239139
ADI Acceptable Daily Intake
AhR Aryl hydrocarbon Receptor
AR Androgen Receptor
BC Breast Cancer
BMI Body Mass Index
BPA Bisphenol A
BRCA1/2 Breast Cancer type 1/2 susceptibility protein
DDE Dichlorodiphenyldichloroethylene
DDT Dichlorodiphenyltrichloroethane
DES Diethylstilbestrol or stilbestrol
DNMTs DNA methyltransferases
EDCs Endocrine Disrupting Chemicals
EPA Environmental Protection Agency
ERα/β Estrogen Receptor α/β
ERE Estrogen Response Elements
ERRγ Estrogen-Related Receptor γ
FDA Food and Drug Administration
GPR30 G Protein-coupled Receptor 30
HER2 Human Epidermal Growth Factor Receptor 2
HRT Hormone Replacement Therapy
IARC International Agency for Research on Cancer
LOAEL Lowest Observed Adverse Effect Level
miRNA microRNA
mRNA messenger RNA
NOAEL No Observable Adverse Effect Level
PDCD4 Programmed Cell Death Protein 4
POP Persistent Organic Pollutant
PR Progesterone Receptor
SR Steroid Receptor
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin
TEB Terminal End Buds
TEQ Toxic Equivalent
TNBC Triple Negative Breast Cancer
WHO World Health Organization